News
2h
Zacks Investment Research on MSNVertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for InvestorsIn the latest close session, Vertex Pharmaceuticals (VRTX) was down 1.73% at $464.20. The stock trailed the S&P 500, which registered a daily loss of 0.4%. At the same time, the Dow lost 0.98%, and ...
8h
Zacks Investment Research on MSNVertex (VERX) Moves 5.0% Higher: Will This Strength Last?Vertex VERX shares rallied 5% in the last trading session to close at $36.21. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results